Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-09-15 Payson Norman Director Sale −800 $60.86 $49K 747,256
2021-09-14 Livingston Mark S. Chief Financial Officer Shares withheld for taxes −117 $57.17 $7K 90,231
2021-09-09 Payson Norman Director Sale −7,430 $58.36 $434K 756,486
2021-09-09 Payson Norman Director Sale −900 $58.62 $53K 755,586
2021-09-08 Payson Norman Director Sale −5,974 $57.18 $342K 766,272
2021-09-08 Payson Norman Director Sale −2,356 $57.87 $136K 763,916
2021-09-03 Schlanger David J Chief Executive Officer Exercise or conversion +50,000 $0.91 $46K 50,000
2021-09-03 Schlanger David J Chief Executive Officer Sale −900 $55.63 $50K 49,100
2021-09-03 Schlanger David J Chief Executive Officer Sale −15,152 $56.58 $857K 33,948
2021-09-03 Schlanger David J Chief Executive Officer Sale −33,948 $57.48 $2.0M 0
2021-09-03 Schlanger David J Chief Executive Officer Exercise or conversion · Employee Stock Option (right to buy) −50,000 2,684,384
2021-09-02 Schlanger David J Chief Executive Officer Exercise or conversion +50,000 $0.91 $46K 50,000
2021-09-02 Schlanger David J Chief Executive Officer Sale −13,800 $56.00 $773K 36,200
2021-09-02 Schlanger David J Chief Executive Officer Sale −36,200 $56.37 $2.0M 0
2021-09-02 Schlanger David J Chief Executive Officer Exercise or conversion · Employee Stock Option (right to buy) −50,000 2,734,384
2021-09-02 Payson Norman Director Sale −5,958 $56.11 $334K 774,618
2021-09-02 Payson Norman Director Sale −2,372 $56.50 $134K 772,246
2021-09-01 Schlanger David J Chief Executive Officer Exercise or conversion +50,000 $0.91 $46K 50,000
2021-09-01 Schlanger David J Chief Executive Officer Sale +18,422 $55.72 $1.0M 31,578
2021-09-01 Schlanger David J Chief Executive Officer Sale −31,578 $56.32 $1.8M 0

Page 71 of 77 · 1,524 trades